Biotechnology
Abstract
The United States biotechnology industry has grown tremendously since 1992, with revenues increasing from $8 billion in 1992 to $39.2 billion in 2003. As a result, biotechnology has revolutionized the way scientists view living matter their research and development efforts have led to the commercialization of many diverse products which have dramatically improved human and animal health, the world's food supply, and the quality of the environment. These successful applications of biotechnology are now viewed by private sector companies as well as governments throughout the world as being the catalysts of long-term economic growth, prosperity, and security. However, the United States, considered the current world leader in biotechnology, is being challenged by Asia for technological preeminence in this field. No longer content to dominate labor-intensive manufacturing, Asian governments are actively promoting biotechnology, nanotechnology, and information technology, and envision themselves becoming world leaders in these technologies three areas that are likely to generate the next wave of global technological innovation. This report summarizes the current state-of-the-art in biotechnology along with its economic and national security implications and examines biotechnology in the broader global context.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2005
- Accession Number
- ADA449474
Entities
People
- Angie Annaballi
- Ceceila Royster
- Chris Ray
- Dave Jerome
- Jill Beaver
- Jiri Gajdos
- John Collie
- Linda Ngo
- Mike Schalck
- Rafael Dejesus
- Stewart Leblanc
Organizations
- Dwight D. Eisenhower School for National Security and Resource Strategy